The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C-Reference-Cited by-同舟云学术

The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C

Published:2004-04 Issue:4 Volume:40 Page:675-681
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Hassanein Tarek,Cooksley Graham,Sulkowski Mark,Smith Coleman,Marinos George,Lai Ming-Yang,Pastore Giuseppe,Trejo-Estrada Rafael,Horta e Vale Ana,Wintfeld Neil,Green Jesse

Publisher

Elsevier BV

Subject

Hepatology

Reference28 articles.

1. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994;Alter;N Engl J Med,1999

2. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related disease;MMWR,1998

3. Projecting the future healthcare burden from hepatitis C in the United States;Davis;Hepatology,1998

4. National Institutes of Health Consensus Development Conference Panel Statement: Management of Hepatitis C;Hepatology,1997

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Interferon-Based Treatment on Quality of Life and Work-Related Productivity of Korean Patients with Chronic Hepatitis C;Gut and Liver;2020-05-15

2. Interferon-Free Regimen: Equally Effective in Treatment Naive and Experienced HCV Patients;Annals of Hepatology;2019-01

3. Patient-reported outcomes in individuals with hepatitis C virus infection treated with elbasvir/grazoprevir;Patient Preference and Adherence;2018-12

4. Burden of disease in patients with chronic hepatitis C in the Austrian REAL study;Wiener klinische Wochenschrift;2018-11-14

5. Chronic Hepatitis C Treatment with Daclatasvir Plus Asunaprevir Does Not Lead to a Decreased Quality of Life;Internal Medicine;2018-07-15